Evidence map›Paper›PMID 27580660›Full record

ReviewEndocrine-related cancer2016

Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases.

Ju-Yeun Moon, Man Ho Choi, Jayoung Kim

Open access · hybridAbstract readReview
In one paragraph

Review in Endocrine-related cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Impact of aNutrients · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ju-Yeun MoonMolecular Recognition Research CenterKorea Institute of Science and Technology, Seoul, Korea.
Man Ho ChoiMolecular Recognition Research CenterKorea Institute of Science and Technology, Seoul, Korea mh_choi@kist.re.kr Jayoung.Kim@cshs.org.
Jayoung KimDepartments of Surgery and Biomedical SciencesCedars-Sinai Medical Center, Los Angeles, California, USA Department of MedicineUniversity of California, Los Angeles, California, USA mh_choi@kist.re.kr Jayoung.Kim@cshs.org.
Korea Institute of Science and Technology · KRUniversity of California, Los Angeles · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
MAPP Research NetworkU01DK082316 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LANDIS, J RICHARD · 2008 to 2018
$17.2M
West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
The Epidemiology of Interstitial Cystitis in a Nationwide Multiethnic VA CohortU01DP006079 · DP · CEDARS-SINAI MEDICAL CENTER · PI ANGER, JENNIFER TASH, FREEDLAND, STEPHEN JAY · 2015 to 2019
$3.8M
Microbiome and Proteome As Predictive Biomarkers of UCPPSU01DK103260 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI ANGER, JENNIFER TASH, FREEMAN, MICHAEL R · 2014 to 2018
$1.2M
Urinary Metabolites in IC PBS DiagnosisR01DK100974 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI ANGER, JENNIFER TASH, KIM, JAYOUNG · 2013 to 2013
$416k
NCATS NIH HHS UL1 TR000124NCCDPHP CDC HHS U01 DP006079NIDDK NIH HHS R01 DK100974NIDDK NIH HHS U01 DK082316NIDDK NIH HHS U01 DK103260NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

Cholesterol and sex steroid hormones including androgens and estrogens play a critical role in the development and progression of urological diseases such as prostate cancer. This disease remains the most commonly diagnosed malignant tumor in men and is the leading cause of death from different cancers. Attempts to understand the role of cholesterol and steroid metabolism in urological diseases have been ongoing for many years, but despite this, our mechanistic and translational understanding remains elusive. In order to further evaluate the problem, we have taken an interest in metabolomics; a discipline dedicated to the systematic study of biologically active metabolites in cells, tissues, hair and biofluids. Recently, we provided evidence that a quantitative measurement of cholesterol and sex steroid metabolites can be successfully achieved using hair of human and mouse models. The overall goal of this short review article is to introduce current metabolomic technologies for the quantitative biomarker assay development and also to provide new insight into understanding the underlying mechanisms that trigger the pathological condition. Furthermore, this review will place a particular emphasis on how to prepare biospecimens (e.g., hair fiber), quantify molecular profiles and assess their clinical significance in various urological diseases.

Indexed as

MetabolomicsAnimalsCell Transformation, NeoplasticCholesterolDisease ProgressionGonadal Steroid HormonesHumansMaleMonitoring, PhysiologicProstatic NeoplasmsUrologic DiseasesCholesterolGonadal Steroid Hormonesbiomarkerscholesterolmass spectrometrymetabolomicsprostate diseasessteroidurological cancers

Identifiers

PMID27580660
PMCPMC5064754
OpenAlexW2518578541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.